Press Release: FDA approves Novartis Cosentyx(R) as the firs

Press Release: FDA approves Novartis Cosentyx(R) as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade

Press Release: FDA approves Novartis Cosentyx(R) as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade

finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , A Hidradenitis Suppurativa , Alexab Kimball , Donna Atherton , Professor Of Dermatology At Harvard Medical School , Exchange Commission , Novartis , Drug Administration , International Association Of Hidradenitis Suppurativa Network , Harvard Medical School , Harvard Medical Faculty Physicians , Beth Israel Deaconess Medical Center , Chief Mission Officer , International Association , Hidradenitis Suppurativa Network , Hidradenitis Suppurativa Clinical Response , Victor Bult , Dow Jones ,